The complex operates in normal mode. Besides, it recruits staff and promises to prevent interruptions in supplying products.
BioTech Rosva quickly responds to changing economic conditions and adapts to the new reality, including those caused by logistical and other restrictions, and continues to fulfill all its obligations to partners and its workforce. The management of the enterprise has formed a plan of anti-crisis measures to minimize the impact of sanctions pressure. Options for working in the new economic conditions are being considered. New sales markets for products are being developed, transport and logistics schemes are being reoriented, and new suppliers are being considered.
“In the current situation it is difficult to make predictions. We strive to ensure production according to plan. We are closely monitoring the situation and will make decisions as it develops,” said CEO of BioTech Rosva JSC.